Zobrazeno 1 - 10
of 166
pro vyhledávání: '"zuranolone"'
Autor:
Adarsh Raja, Saboor Ahmed, Muhammad Basit Ali Siddiqui, Syeda Lamiya Mir, Rakesh Kumar, Muhammad Ahmed, Sandesh Raja, Shafin Bin Amin, Hafsah Alim Ur Rahman, Fnu Deepak, Muhammad Sohaib Asghar
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
IntroductionMajor depressive disorder (MDD), postpartum depression (PPD), and insomnia are neuropsychological conditions in which zuranolone is used to improve symptoms and prognosis of the disorder. This meta-analysis aimed to determine the efficacy
Externí odkaz:
https://doaj.org/article/44dca5340e3c43299d3fc43cd8b807c0
Autor:
Abdullah Ahmad, Abdul Rafeh Awan, Natasha Nadeem, Aamir Shahid Javed, Mobeen Farooqi, Muhammed Daniyal, Hassan Mumtaz
Publikováno v:
Frontiers in Neuroscience, Vol 18 (2024)
BackgroundCurrent treatment modalities for Major Depressive Disorder have variable efficacies and a variety of side effects. To amend this, many trials for short term, well tolerated monotherapies are underway. One such option is Zuranolone (SAGE-217
Externí odkaz:
https://doaj.org/article/0e203e905e384fa482ca31dd70c3bce9
Publikováno v:
Frontiers in Neuroscience, Vol 17 (2024)
ObjectiveThis study aimed to systematically review zuranolone’s efficacy and safety in treating major depressive disorder (MDD).MethodsWe conducted electronic searches in databases like PubMed, Embase, Cochrane, and Web of Science to identify rando
Externí odkaz:
https://doaj.org/article/4cc0d7c9cfae4dac8510e85549c5036b
Autor:
Youjia Qiu, Yuchen Tao, Aojie Duan, Xingzhou Wei, Menghan Wang, Minjia Xie, Zhouqing Chen, Jing Shang, Zhong Wang
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2024)
Background: As a novel antidepressant drug, zuranolone has been initially applied in treating depression. This study investigated the efficacy and safety of its administration in patients with depression.Methods: The Embase, PubMed, and Cochrane libr
Externí odkaz:
https://doaj.org/article/c5ff86f4c4a9431e82f090ed257f8fde
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
With each passing year, the number of people suffering from mental disorders grows at a disturbing speed. Neuroactive steroids are a new promising group of drugs with the potential for use in many diseases like postpartum depression, postnatal psycho
Externí odkaz:
https://doaj.org/article/028367436b8549ba88b68a21e172f1aa
Autor:
Yu-Wei Lin, Yu-Kang Tu, Kuo-Chuan Hung, Chih-Sung Liang, Ping-Tao Tseng, Pao-Yen Lin, Edward Chia-Cheng Lai, Chih-Wei Hsu
Publikováno v:
EClinicalMedicine, Vol 66, Iss , Pp 102308- (2023)
Summary: Background: Zuranolone is recognised as a promising antidepressant agent. Our study aimed to investigate the efficacy and safety of zuranolone in treating major depressive disorder (MDD). Methods: A systematic review was conducted by searchi
Externí odkaz:
https://doaj.org/article/9c4bd722504f478eb5bbaa9a173120d9
Neurosteroid Modulation of Synaptic and Extrasynaptic GABAA Receptors of the Mouse Nucleus Accumbens
Autor:
Scott J. Mitchell, Grant D. Phillips, Becks Tench, Yunkai Li, Delia Belelli, Stephen J. Martin, Jerome D. Swinny, Louise Kelly, John R. Atack, Michael Paradowski, Jeremy J. Lambert
Publikováno v:
Biomolecules, Vol 14, Iss 4, p 460 (2024)
The recent approval of formulations of the endogenous neurosteroid allopregnanolone (brexanolone) and the synthetic neuroactive steroid SAGE-217 (zuranolone) to treat postpartum depression (PPD) has encouraged further research to elucidate why these
Externí odkaz:
https://doaj.org/article/e9f4ea689ff047bdb0ce891c119b69a6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.